Scholarlink

<p>Pancreatic ductal adenocarcinoma (PDAC) has a dismal prognosis due to treatment resistance and an immunosuppressive, fibrotic microenvironment. Ferroptosis, a novel form of regulated cell death, offers a promising therapeutic strategy. Transcriptomic datasets GSE28735 and GSE62452 were integrated for differential expression and WGCNA. Ferroptosis-related genes were intersected, followed by machine learning (LASSO, SVM-RFE, etc.) to screen core genes. Enrichment, immune infiltration, and single-cell transcriptome (GSE197177) analyses were performed. Clinical validation used HPA and TCGA. Resveratrol effects were assessed by molecular docking, CCK-8, Western blot, and ferroptosis inhibitor rescue assays (GSH measurement, Fer-1 intervention). Twenty-seven PDAC ferroptosis-related genes were identified, and five core genes were refined by machine learning. Single-cell analysis further confirmed six key genes: GPX4, CTSB, NOX4, TFRC, HIF1A, and TGFB1. They were significantly enriched in ferroptosis, HIF-1, and TGF-β pathways. M1/M2 macrophages showed notable infiltration and correlated with gene expression. Clinical validation revealed high CTSB/TFRC protein expression in PDAC; high TGFB1 predicted poor prognosis. In vitro, resveratrol downregulated multiple key proteins, suppressed tumor cell activity, and enhanced ferroptosis sensitivity. Ferroptosis inhibitor (Fer-1) partially reversed resveratrol-induced GSH depletion and protein changes, confirming ferroptosis involvement. This study unveils a ferroptosis regulatory network in PDAC involving HIF-1/TGF-β signaling and macrophage crosstalk. Resveratrol targets this network to induce ferroptosis, offering novel biomarkers and a potential therapeutic strategy for PDAC.</p> Graphical Abstract <p></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Integrative multi-omics analysis identifies a core ferroptosis signature and validates resveratrol as a novel inducer in pancreatic cancer

  • 期刊论文

  • 发表日期：

    2026年5月16日

查看全文
  • Wenji Diao,
  • Fei Liu

摘要

Pancreatic ductal adenocarcinoma (PDAC) has a dismal prognosis due to treatment resistance and an immunosuppressive, fibrotic microenvironment. Ferroptosis, a novel form of regulated cell death, offers a promising therapeutic strategy. Transcriptomic datasets GSE28735 and GSE62452 were integrated for differential expression and WGCNA. Ferroptosis-related genes were intersected, followed by machine learning (LASSO, SVM-RFE, etc.) to screen core genes. Enrichment, immune infiltration, and single-cell transcriptome (GSE197177) analyses were performed. Clinical validation used HPA and TCGA. Resveratrol effects were assessed by molecular docking, CCK-8, Western blot, and ferroptosis inhibitor rescue assays (GSH measurement, Fer-1 intervention). Twenty-seven PDAC ferroptosis-related genes were identified, and five core genes were refined by machine learning. Single-cell analysis further confirmed six key genes: GPX4, CTSB, NOX4, TFRC, HIF1A, and TGFB1. They were significantly enriched in ferroptosis, HIF-1, and TGF-β pathways. M1/M2 macrophages showed notable infiltration and correlated with gene expression. Clinical validation revealed high CTSB/TFRC protein expression in PDAC; high TGFB1 predicted poor prognosis. In vitro, resveratrol downregulated multiple key proteins, suppressed tumor cell activity, and enhanced ferroptosis sensitivity. Ferroptosis inhibitor (Fer-1) partially reversed resveratrol-induced GSH depletion and protein changes, confirming ferroptosis involvement. This study unveils a ferroptosis regulatory network in PDAC involving HIF-1/TGF-β signaling and macrophage crosstalk. Resveratrol targets this network to induce ferroptosis, offering novel biomarkers and a potential therapeutic strategy for PDAC.

Graphical Abstract